Please enable JavaScript to continue using this application.

Compare $FHTX vs $PMVP | Chartloom

Compare

$FHTX vs $PMVP

Foghorn Therapeutics Inc · PMV Pharmaceuticals Inc

FHTX

Foghorn Therapeutics Inc

PMVP

PMV Pharmaceuticals Inc

Compare $FHTX vs $PMVP

Comparing Foghorn Therapeutics Inc and PMV Pharmaceuticals Inc

FHTXFoghorn Therapeutics Inc

PMVPPMV Pharmaceuticals Inc

FHTXFoghorn Therapeutics Inc

Market cap

$117M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.04x

Rev growth (TTM)

52.0%

YTD performance

-61.5%

52W performance

-55.6%

FCF yield

-71.8%

PMVPPMV Pharmaceuticals Inc

Market cap

$81M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.6%

52W performance

7.0%

FCF yield

-87.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FHTX

PMVP

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

FHTX$117M

PMVP$81M

Enterprise Value

FHTX$49M

PMVP$69M

Price

FHTX$2.00

PMVP$1.52

P/E Ratio

FHTXN/A

PMVPN/A

P/S Ratio

FHTX3.20x

PMVP0.00x

EV/Sales

FHTX1.34x

PMVP0.00x

EV/EBITDA

FHTX0.00x

PMVP0.00x

P/B Ratio

FHTX1,199.58x

PMVP1.89x

P/FCF Ratio

FHTXN/A

PMVPN/A

EV/FCF

FHTX-0.59x

PMVP-0.96x

PEG Ratio

FHTXN/A

PMVPN/A

Forward P/E (NTM)

FHTXN/A

PMVPN/A

Forward P/S (NTM)

FHTX4.04x

PMVPN/A

Revenue (TTM)

FHTX$37M

PMVP$0

Revenue Growth (YoY)

FHTX52.0%

PMVPN/A

Forward Rev Growth

FHTX7.3%

PMVP546.2%

Gross Margin (TTM)

FHTX0.0%

PMVP0.0%

Operating Margin (TTM)

FHTX0.0%

PMVP0.0%

EBITDA Margin (TTM)

FHTX-180.6%

PMVP0.0%

Net Margin (TTM)

FHTX-175.8%

PMVP0.0%

FCF Margin (TTM)

FHTX-229.4%

PMVPN/A

Net Income (TTM)

FHTX$-65M

PMVP$-75M

FCF (TTM)

FHTX$-84M

PMVP$-71M

EPS (TTM)

FHTX-$0.91

PMVP-$1.41

ROE (TTM)

FHTX-30161.0%

PMVP-7811.0%

ROA (TTM)

FHTX-3117.0%

PMVP-7013.0%

ROIC (TTM)

FHTX-30161.0%

PMVP-7811.0%

Cash

FHTX$68M

PMVP$12M

Debt

FHTX$0

PMVP$0

Net Cash/Debt

FHTX$68M

PMVP$12M

Current Ratio (TTM)

FHTX3.36x

PMVP7.70x

Quick Ratio (TTM)

FHTX3.31x

PMVP7.52x

Debt/Equity (TTM)

FHTX0.00x

PMVP0.00x

Debt/Assets (TTM)

FHTX0.0%

PMVP0.0%

Interest Coverage (TTM)

FHTXN/A

PMVPN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

PMVP0.00x

Beta

FHTX3.13

PMVP1.48

52W Performance

FHTX-55.6%

PMVP7.0%

YTD Performance

FHTX-61.5%

PMVP23.6%

% from 52W High

FHTX-73.7%

PMVP-20.4%

% from 52W Low

FHTX11.7%

PMVP49.0%

Asset Turnover (TTM)

FHTX0.18x

PMVP0.00x

FCF Yield (TTM)

FHTX-71.8%

PMVP-87.9%

Earnings Yield (TTM)

FHTX-55.0%

PMVP-92.8%

Dividend Yield (TTM)

FHTXN/A

PMVPN/A

Rule of 40

FHTX-177.4

PMVP0.0

EV/GP/RG

FHTXN/A

PMVPN/A

Ticker research

View FHTX research View PMVP research

Metric	FHTX Foghorn Therapeutics Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$117M	$81M
Enterprise Value	$49M	$69M
Price	$2.00	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	0.00x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	546.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-75M
FCF (TTM)	$-84M	$-71M
EPS (TTM)	-$0.91	-$1.41
ROE (TTM)	-30161.0%	-7811.0%
ROA (TTM)	-3117.0%	-7013.0%
ROIC (TTM)	-30161.0%	-7811.0%
Financial Health
Cash	$68M	$12M
Debt	$0	$0
Net Cash/Debt	$68M	$12M
Current Ratio (TTM)	3.36x	7.70x
Quick Ratio (TTM)	3.31x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.48
52W Performance	-55.6%	7.0%
YTD Performance	-61.5%	23.6%
% from 52W High	-73.7%	-20.4%
% from 52W Low	11.7%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-71.8%	-87.9%
Earnings Yield (TTM)	-55.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View PMVP research

Valuation

P/S Ratio

PMVP

0.00x

FHTX

3.20x

EV/FCF

PMVP

-0.96x

FHTX

-0.59x

Growth & revenue

Revenue Growth TTM

FHTX

52.0%

Forward Revenue Growth

PMVP

546.2%

FHTX

7.3%

Profitability & performance

Gross Margin

FHTX

0.0%

PMVP

0.0%

ROE

PMVP

-7811.0%

FHTX

-30161.0%

FCF Yield %

FHTX

-71.8%

PMVP

-87.9%

52-Week Performance

PMVP

7.0%

FHTX

-55.6%

Detailed metrics comparison

FHTX

Foghorn Therapeutics Inc

PMVP

PMV Pharmaceuticals Inc

Market Cap

FHTX$117M

PMVP$81M

Enterprise Value

FHTX$49M

PMVP$69M

Price

FHTX$2.00

PMVP$1.52

P/E Ratio

FHTXN/A

PMVPN/A

P/S Ratio

FHTX3.20x

PMVP0.00x

EV/Sales

FHTX1.34x

PMVP0.00x

EV/EBITDA

FHTX0.00x

PMVP0.00x

P/B Ratio

FHTX1,199.58x

PMVP1.89x

P/FCF Ratio

FHTXN/A

PMVPN/A

EV/FCF

FHTX-0.59x

PMVP-0.96x

PEG Ratio

FHTXN/A

PMVPN/A

Forward P/E (NTM)

FHTXN/A

PMVPN/A

Forward P/S (NTM)

FHTX4.04x

PMVPN/A

Revenue (TTM)

FHTX$37M

PMVP$0

Revenue Growth (YoY)

FHTX52.0%

PMVPN/A

Forward Rev Growth

FHTX7.3%

PMVP546.2%

Gross Margin (TTM)

FHTX0.0%

PMVP0.0%

Operating Margin (TTM)

FHTX0.0%

PMVP0.0%

EBITDA Margin (TTM)

FHTX-180.6%

PMVP0.0%

Net Margin (TTM)

FHTX-175.8%

PMVP0.0%

FCF Margin (TTM)

FHTX-229.4%

PMVPN/A

Net Income (TTM)

FHTX$-65M

PMVP$-75M

FCF (TTM)

FHTX$-84M

PMVP$-71M

EPS (TTM)

FHTX-$0.91

PMVP-$1.41

ROE (TTM)

FHTX-30161.0%

PMVP-7811.0%

ROA (TTM)

FHTX-3117.0%

PMVP-7013.0%

ROIC (TTM)

FHTX-30161.0%

PMVP-7811.0%

Cash

FHTX$68M

PMVP$12M

Debt

FHTX$0

PMVP$0

Net Cash/Debt

FHTX$68M

PMVP$12M

Current Ratio (TTM)

FHTX3.36x

PMVP7.70x

Quick Ratio (TTM)

FHTX3.31x

PMVP7.52x

Debt/Equity (TTM)

FHTX0.00x

PMVP0.00x

Debt/Assets (TTM)

FHTX0.0%

PMVP0.0%

Interest Coverage (TTM)

FHTXN/A

PMVPN/A

Net Debt/EBITDA (TTM)

FHTX0.00x

PMVP0.00x

Beta

FHTX3.13

PMVP1.48

52W Performance

FHTX-55.6%

PMVP7.0%

YTD Performance

FHTX-61.5%

PMVP23.6%

% from 52W High

FHTX-73.7%

PMVP-20.4%

% from 52W Low

FHTX11.7%

PMVP49.0%

Asset Turnover (TTM)

FHTX0.18x

PMVP0.00x

FCF Yield (TTM)

FHTX-71.8%

PMVP-87.9%

Earnings Yield (TTM)

FHTX-55.0%

PMVP-92.8%

Dividend Yield (TTM)

FHTXN/A

PMVPN/A

Rule of 40

FHTX-177.4

PMVP0.0

EV/GP/RG

FHTXN/A

PMVPN/A

Ticker research

View FHTX research View PMVP research

Metric	FHTX Foghorn Therapeutics Inc	PMVP PMV Pharmaceuticals Inc
Market & Valuation
Market Cap	$117M	$81M
Enterprise Value	$49M	$69M
Price	$2.00	$1.52
P/E Ratio	N/A	N/A
P/S Ratio	3.20x	0.00x
EV/Sales	1.34x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1,199.58x	1.89x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.59x	-0.96x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	4.04x	N/A
Revenue & Growth
Revenue (TTM)	$37M	$0
Revenue Growth (YoY)	52.0%	N/A
Forward Rev Growth	7.3%	546.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-180.6%	0.0%
Net Margin (TTM)	-175.8%	0.0%
FCF Margin (TTM)	-229.4%	N/A
Net Income (TTM)	$-65M	$-75M
FCF (TTM)	$-84M	$-71M
EPS (TTM)	-$0.91	-$1.41
ROE (TTM)	-30161.0%	-7811.0%
ROA (TTM)	-3117.0%	-7013.0%
ROIC (TTM)	-30161.0%	-7811.0%
Financial Health
Cash	$68M	$12M
Debt	$0	$0
Net Cash/Debt	$68M	$12M
Current Ratio (TTM)	3.36x	7.70x
Quick Ratio (TTM)	3.31x	7.52x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.13	1.48
52W Performance	-55.6%	7.0%
YTD Performance	-61.5%	23.6%
% from 52W High	-73.7%	-20.4%
% from 52W Low	11.7%	49.0%
Efficiency & Yields
Asset Turnover (TTM)	0.18x	0.00x
FCF Yield (TTM)	-71.8%	-87.9%
Earnings Yield (TTM)	-55.0%	-92.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-177.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FHTX research	View PMVP research